116
Participants
Start Date
May 1, 2015
Primary Completion Date
December 21, 2018
Study Completion Date
December 21, 2018
Engerix-B
The case group will receive 5 Engerix-B injections during the last 6 months of a 3-year NA therapy.
Tenofovir
Both case and control will receive 300 mg Tenofovir for at least 3 years
Entecavir
Both case and control will receive 0.5 mg entecavir therapy for at least 3 years
Chang Gung Memorial Hospital, Taipei
Chang Gung Memorial Hospital
OTHER